Gastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

Two new studies appearing in Annals of Allergy Asthma & Immunology and being presented at the American College of Allergy, ...

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

Irving-based Kimberly-Clark announced a blockbuster deal Monday morning to acquire consumer health care company Kenvue for ...

An Upstate pediatrician is transforming the way she treats her young patients by prescribing books alongside traditional ...

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

Curd and fermented foods have long been trusted in Indian homes for promoting gut health. But when it comes to babies, the question often arises—are these probiotic-rich foods truly safe? This article ...

The researchers conclude that the findings underscore the need to screen prematurely born babies — and, in particular, those ...